CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0103)

Sherbrooke, Quebec J1H 5N4

0 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic Gastroesophageal Adenocarcinoma, Carcinoma, Nonsquamous Non-small-cell Lung

Studies at this site

• Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) — Completed
• Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015) — Completed